Top

World Journal of Surgery

Published in:

01-02-2009

Pilot Postoperative Ileus Study of Escin in Cancer Patients After Colorectal Surgery

Authors: Qiwei Xie, Xianglong Zong, Baoming Ge, Shan Wang, Jiafu Ji, Yingjiang Ye, Lili Pan

Published in: World Journal of Surgery | Issue 2/2009

Abstract

Background

Postoperative ileus, a common complication in patients after abdominal surgery, brings no benefit to the recovery of postoperative patients, and treatment targeted at restoring gastrointestinal motility may shorten the hospital stay. Studies have shown that escin accelerates gastrointestinal transit in mice and improves gastrointestinal motility in patients after abdominal surgery. A pilot study of escin’s effect on the recovery of gastrointestinal motility was conducted in colorectal cancer patients in anticipation of a multiple-center randomized controlled trial.

Methods

A total of 72 postoperative colorectal cancer patients were randomly assigned to four parallel groups on the basis of sealed envelopes—escin 5 mg group (E5 mg), escin 15 mg group (E15 mg), escin 25 mg group (E25 mg), and placebo group—with 18 patients in each group. Escin or placebo was diluted in 500 ml 5% dextrose injection, which was given once daily through the subclavian vein. The first injection took place 6 h after completion of the surgery. The treatment continued for 7 days or stopped at the time of the patient’s first bowel movement. Time to recovery of passage of gas (TRPG), time to recovery of gastrointestinal sounds (TRGS), and time to recovery of bowel movements (TRBM) were recorded to evaluate the efficacy of escin.

Results

The TRPGs of the three escin treatment groups were 76.78 + 28.81 h (E5 mg), 72.06 + 14.65 h (E15 mg), and 65.50 + 26.70 h (E25 mg), respectively, with differences of 6.03 ± 7.64 h (p = 0.436; E5 mg), 10.75 ± 4.92 h (p = 0.036; E15 mg), and 17.31 ± 7.20 h (p = 0.022; E25 mg) compared with the placebo group. The TRGSs of the three escin treatment groups were 45.28 ± 26.15 h (E5 mg), 41.22 ± 16.98 h (E15 mg), and 40.33 ± 14.09 h (E25 mg), respectively, with differences of 4.33 ± 7.12 h (p = 0.547; E5 mg), 8.39 ± 5.36 h (p = 0.127; E15 mg), and 9.28 ± 4.87 h (p = 0.065; E25 mg) compared with the placebo group. The TRBMs of the three escin treatment groups were 89.25 ± 23.77 h (E5 mg), 84.83 ± 27.91 h (E15 mg), and 84.44 ± 19.74 h (E25 mg), respectively, with differences of 19.03 ± 10.13 h (p = 0.069; E5 mg), 23.44 ± 10.70 h (p = 0.035; E15 mg), and 23.83 ± 9.63 h (p = 0.019; E25 mg) compared with the placebo group.

Conclusion

The results of this pilot Postoperative Ileus Study of Escin (PISE) showed that escin can shorten the time to recovery of gastrointestinal motility in cancer patients after colorectal surgery.

Holte K, Kehlet H (2000) Postoperative ileus: a preventable event. Br J Surg 87:1480–1493PubMedCrossRef

Miedema BW, Johnson JO (2003) Methods for decreasing postoperative gut dysmotility. Lancet Oncol 4:365–372PubMedCrossRef

Baig MK, Wexner SD (2004) Postoperative ileus: a review. Dis Colon Rectum 47:516–526PubMedCrossRef

Guillaume M, Padioleau F (1994) Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. Arzneimittelforschung 44:25–35PubMed

Liang DC, Yang HL (2004) A randomized controlled trial of escin in patients after surgery of lumber disc herniation. Chin J Spine Spinal Cord 40:617–618

Yan WC, Gao KS (2005) A randomized, controlled trial of escin for the treatment of acute cerebral infarction in senior patients. Chin J Gerontol 25:272–273

Dong GX, Wang ZG, Liang FQ et al (2003) The effect of escin on chronic venous insufficiency: a randomized controlled multi-centered clinical trial. Chin J Gen Surg 18:206–208

Matsuda H, Li Y, Yoshikawa M (2000) Possible involvement of dopamine and dopamine2 receptors in the inhibitions of gastric emptying by escin Ib in mice. Life Sci 67:2921–2927PubMedCrossRef

Matsuda H, Li Y, Yoshikawa M (2000) Roles of endogenous prostaglandins and nitric oxide in inhibitions of gastric emptying and accelerations of gastrointestinal transit by escins Ia, Ib, IIa, and IIb in mice. Life Sci 66:PL41–PL46CrossRef

10.

Matsuda H, Li Y, Yoshikawa M (1999) Effects of escins Ia, Ib, IIa, and IIb from horse chestnuts on gastrointestinal transit and ileus in mice. Bioorg Med Chem 7:1737–1741PubMedCrossRef

11.

Matsuda H, Li Y, Yoshikawa M (2000) Possible involvement of 5-HT and 5-HT2 receptors in acceleration of gastrointestinal transit by escin Ib in mice. Life Sci 66:2233–2238PubMedCrossRef

12.

Fu FH, Hou YZ, Jiang WL et al (2005) Escin: inhibiting inflammation and promoting gastrointestinal transit to attenuate formation of postoperative adhesions. World J Surg 29:1614–1620PubMedCrossRef

13.

Hellerg K, Ruschewski W, De Vivie R (1975) Drug induced acute renal failure after heart surgery. Thoraxchirurgie 23:396–399

14.

Holte K, Kehlet H (2000) Postoperative ileus: a preventable event. Br J Surg 87:1480–1493PubMedCrossRef

15.

Brown TA, McDonald J, Williard W (1999) A prospective, randomized, double-blinded, placebo-controlled trial of cisapride after colorectal surgery. Am J Surg 177:399–401PubMedCrossRef

16.

Lander A, Redkar R, Nicholls G et al (1997) Cisapride reduces neonatal postoperative ileus: randomized placebo controlled trial. Arch Dis Child 77:F119–F122

17.

Cheatham ML, Chapman WC, Key SP et al (1995) A meta-analysis of selective versus routine nasogastric decompression after elective laparotomy. Ann Surg 221:469–476PubMedCrossRef

18.

Sagar PM, Kruegener G, MacFie J (1992) Nasogastric intubation and elective abdominal surgery. Br J Surg 79:1127–1131PubMedCrossRef

19.

Rao SS, Beaty J, Chamberlain M et al (1999) Effects of acute graded exercise on human colonic motility. Am J Physiol 276:G1221–G1226PubMed

20.

Waldhausen JH, Schirmer BD (1990) The effect of ambulation on recovery from postoperative ileus. Ann Surg 212:671–677PubMedCrossRef

21.

Allen C, Glaszious P, Del Mar C (1999) Bed rest: a potentially harmful treatment needing more careful evaluation. Lancet 354:1229–1233PubMedCrossRef

22.

Schilder JM, Hurteau JA, Look KY et al (1997) A prospective controlled trial of early postoperative oral intake following majaor abdominal gynecologic surgery. Gymecol Oncol 67:235–240CrossRef

23.

Stewart BT, Woods RJ, Collopy BT et al (1998) Early feeding after elective open colorectal resections:a prospective randomized trial. Aust N Z Surg 68:125–128CrossRef

24.

Helslin MJ, Latkany L, Leung D et al (1997) A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg 226:567–577CrossRef

25.

Watters JM, Kirkpatrick SM, Norris SB (1997) Immediate postoperative enteral feeding results in impaired respiratory mechanics and decreased mobility. Ann Surg 226:369–377PubMedCrossRef

26.

Tonini M, De Ponti F, Di Nucci A et al (1999) Review article: cardiac adverse effects of gastrointestinal prokinetics. Aliment Pharmacol Ther 13:1585–1591PubMedCrossRef

27.

Bonacini M, Quiason S, Reynolds M et al (1993) Effect of intravenous erythromycin on postoperative ileus. Am J Gastroenterol 88:208–211PubMed

28.

Wang MY, Li HC, Shi HP (1999) Experimental research on prevention of postoperative intestinal adhesion by sodium aescinate. Chin J Surg Integrated Traditional Western Med 5:382–384

29.

Castedal M, Bjornsson E, Abrahamsson H (2000) Effects of midazolam on small bowel motility in humans. Aliment Pharmacol Ther 14:571–577PubMedCrossRef

30.

Wang SJ, Tsai SC, Lin WY et al (2000) A simple method for preparing radioactive capsules in colon transit study. Eur J Nucl Med 27:857–860PubMedCrossRef

31.

Altman DG, Bland JM (1995) Absence of evidence is not evidence of absence. BMJ 311:485PubMed

32.

Shakespeare TP, Gebski VJ, Veness MJ et al (2001) Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours. Lancet 357:1349–1353PubMedCrossRef

33.

Li BH, Zhang J, Huang RZ et al (2006) Effect of pH adjustment of intravenous injection of sodium aescinate after addition of sodium bicarbonate to prevent phlebitis. Zhonghua Hu Li Za Zhi 41:113–115

Title: Pilot Postoperative Ileus Study of Escin in Cancer Patients After Colorectal Surgery
Authors: Qiwei Xie
Xianglong Zong
Baoming Ge
Shan Wang
Jiafu Ji
Yingjiang Ye
Lili Pan
Publication date: 01-02-2009
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 2/2009
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-008-9816-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pilot Postoperative Ileus Study of Escin in Cancer Patients After Colorectal Surgery

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2009

Initial Resection of Potentially Viable Tissue is not Optimal Treatment for Grades II–IV Pancreatic Injuries

Use of Locum Tenens Surgeons to Provide Surgical Care in Small Rural Hospitals

Which Method Should We Select for Pancreatic Anastomosis After Pancreaticoduodenectomy?

Thyroid Resection Improves Perception of Swallowing Function in Patients with Thyroid Disease

Laparoscopic Appendectomy for Complicated Appendicitis: A Comparison with Open Appendectomy

In Memoriam: Martin Allgöwer (1917–2007), Professor Dr med, Dres med hc mult, FACS (Hon), FRCS (Hon), ASA (Hon)